139
Participants
Start Date
January 31, 2003
Study Completion Date
August 31, 2003
cefuroxime plus erythromycin
intravenous cefuroxime 1.5 g twice daily for 4 +/-1 days, followed by oral cefuroxime 0.5 g twice daily for a total duration of 9 +/-1 days plus erythromycin ethylsuccinate 0.5 g twice daily, which was given for a total duration of 14 days for subjects with suspected pneumonia due to atypical pathogens
azithromycin (Zithromax)
intravenous azithromycin 500 mg once daily for 4 +/-1 days, followed by oral azithromycin 500 mg once daily for a total duration of 9 +/-1 days
cefuroxime
intravenous cefuroxime 1.5 g twice daily for 4 +/-1 days, followed by oral cefuroxime 0.5 g twice daily for a total duration of 9 +/-1 days
Pfizer Investigational Site, Beijing
Pfizer Investigational Site, Shanghai
Pfizer Investigational Site, Shanghai
Pfizer Investigational Site, Shanghai
Pfizer Investigational Site, Shanghai
Lead Sponsor
Pfizer
INDUSTRY